About this Research Topic
Human papillomavirus is a leading cause of disease in low- and middle-income countries, particularly in women, causing an essential public health problem and a severe burden to healthcare systems. In 2020, the World Health Organization outlined a global strategy to accelerate the elimination of cervical cancer. To address this public health problem, experts from the National Cancer Institute have integrated a multidisciplinary group of healthcare professionals to create the National Consensus on Cervical Cancer to establish recommendations for the medical community.
This Research Topic aims to bring together the updated recommendations established in the 2023 National Consensus on Cervical Cancer in Mexico.
We welcomed Mini Review articles based on clinical trials and experimental papers published in the last 5 years regarding the epidemiology, diagnosis, screening, treatment, immunotherapy, and prevention of cervical cancer, with a practical application in Mexico.
This Research Topic aims to bring together the updated recommendations established in the 2023 National Consensus on Cervical Cancer in Mexico.
We welcomed Mini Review articles based on clinical trials and experimental papers published in the last 5 years regarding the epidemiology, diagnosis, screening, treatment, immunotherapy, and prevention of cervical cancer, with a practical application in Mexico.
Keywords: HPV, cervical cancer, epidemiology, symbiotics, cancer treatment, immunotherapy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
